| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 33,336 | 46,303 | 52,773 | 57,626 |
| Marketable securities | NaN | NaN | NaN | 0 |
| Prepaid expenses and other current assets | 682 | 629 | 1,637 | 1,402 |
| Prepaid research and development | 723 | 830 | 1,320 | 1,287 |
| Total current assets | 34,741 | 47,762 | 55,730 | 60,315 |
| Property and equipment, net | 826 | 4,107 | 5,159 | 5,340 |
| Right of use assets - operating leases | 651 | 10,168 | 13,001 | 13,273 |
| Other assets | 244 | 244 | 270 | 270 |
| Total assets | 36,462 | 62,281 | 74,160 | 79,198 |
| Accounts payable | 1,310 | 1,113 | 952 | 2,395 |
| Accrued expenses and other current liabilities | 3,895 | 4,653 | 4,001 | 4,073 |
| Non-refundable sublicense and transition services payments | 13,750 | 13,750 | 13,750 | 9,741 |
| Operating lease liabilities | 1,149 | 3,567 | 3,542 | 3,592 |
| Total current liabilities | 20,104 | 23,083 | 22,245 | 19,801 |
| Operating lease liabilities - noncurrent | 4,606 | 20,443 | 20,795 | 21,139 |
| Total liabilities | 24,710 | 43,526 | 43,040 | 40,940 |
| Additional paidin capital | 724,068 | 723,512 | 722,894 | 722,283 |
| Accumulated deficit | -712,316 | -704,757 | -691,774 | -684,025 |
| Total stockholders' equity | 11,752 | 18,755 | 31,120 | 38,258 |
| Total liabilities and stockholders' equity | 36,462 | 62,281 | 74,160 | 79,198 |
Passage BIO, Inc. (PASG)
Passage BIO, Inc. (PASG)